ES511516A0 - Un procedimiento para la preparacion de glicopeptidos. - Google Patents

Un procedimiento para la preparacion de glicopeptidos.

Info

Publication number
ES511516A0
ES511516A0 ES511516A ES511516A ES511516A0 ES 511516 A0 ES511516 A0 ES 511516A0 ES 511516 A ES511516 A ES 511516A ES 511516 A ES511516 A ES 511516A ES 511516 A0 ES511516 A0 ES 511516A0
Authority
ES
Spain
Prior art keywords
mannopyranosylthio
metabolizable
propionyl
lysine
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES511516A
Other languages
English (en)
Other versions
ES8306162A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES511516A0 publication Critical patent/ES511516A0/es
Publication of ES8306162A1 publication Critical patent/ES8306162A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/14—Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES511516A 1981-04-20 1982-04-19 Un procedimiento para la preparacion de glicopeptidos. Expired ES8306162A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/255,416 US4386026A (en) 1981-04-20 1981-04-20 Cell-specific glycopeptide ligands

Publications (2)

Publication Number Publication Date
ES511516A0 true ES511516A0 (es) 1983-05-01
ES8306162A1 ES8306162A1 (es) 1983-05-01

Family

ID=22968229

Family Applications (1)

Application Number Title Priority Date Filing Date
ES511516A Expired ES8306162A1 (es) 1981-04-20 1982-04-19 Un procedimiento para la preparacion de glicopeptidos.

Country Status (10)

Country Link
US (1) US4386026A (es)
EP (1) EP0063373B1 (es)
JP (1) JPS57181095A (es)
AT (1) ATE18562T1 (es)
DE (1) DE3269778D1 (es)
DK (1) DK173282A (es)
ES (1) ES8306162A1 (es)
GR (1) GR76475B (es)
IE (1) IE52473B1 (es)
PT (1) PT74747B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4701521A (en) * 1978-07-17 1987-10-20 The Trustees Of Boston University Method of effecting cellular uptake of molecules
US4466951A (en) * 1982-11-12 1984-08-21 University Of California Intracellular trapping of therapeutics or tracer agents
FR2551442B1 (fr) * 1983-09-05 1987-04-30 Centre Nat Rech Scient Nouveaux derives furaniques, leur preparation et leur application
US4873322A (en) * 1986-01-24 1989-10-10 Ciba-Geigy Corporation Saccharide derivatives and processes for their manufacture
US4946675A (en) * 1987-05-27 1990-08-07 Xoma Corporation Hepatic blocking agents
US5879680A (en) * 1987-12-23 1999-03-09 The United States Of America As Represented By The Department Of Health And Human Services Cloned DNA for synthesizing unique glucocerebrosidase
JPH05503691A (ja) * 1989-12-29 1993-06-17 ユニバーシティ・テクノロジーズ・インターナショナル・インコーポレイテッド アゴニストおよびアンタゴニストを含む生物学的に活性なリガンドの３次構造モデルの設計方法およびアンギオテンシンに基づいた新規合成アンタゴニスト
US5432260A (en) * 1991-05-03 1995-07-11 Washington University High affinity mannose receptor ligands
US5332575A (en) * 1991-10-03 1994-07-26 Parfums Christian Dior Method of targeting melanocytes with a compound containing a fucose residue
EP0647133A4 (en) * 1992-06-12 1997-10-29 Affymax Tech Nv COMPOSITIONS AND METHODS FOR IMPROVED DRUG DELIVERY.
TW263437B (es) * 1992-09-24 1995-11-21 Takeda Pharm Industry Co Ltd
US5508387A (en) * 1993-08-04 1996-04-16 Glycomed Incorporated Selectin binding glycopeptides
WO1995010296A1 (en) * 1993-10-12 1995-04-20 Glycomed Incorporated A library of glyco-peptides useful for identification of cell adhesion inhibitors
JP4256932B2 (ja) * 1995-06-07 2009-04-22 ジョエル ケイ． スワデッシュ 抗原プロセシング細胞標的複合体
US5965719A (en) * 1996-11-15 1999-10-12 Sunsorb Biotech, Inc. Combinatorial synthesis of carbohydrate libraries
WO1998031392A1 (en) * 1997-01-17 1998-07-23 Drug Delivery System Institute, Ltd. Nephrotropic drugs
DE69830305T2 (de) * 1997-02-20 2006-02-02 Dime, David S., Toronto Ortsspezifische arzneimittel verabreichung
US7033765B1 (en) 1997-02-20 2006-04-25 Toronto Research Chemicals, Inc. Site-specific drug delivery
AU6832398A (en) * 1997-03-27 1998-10-22 Institut Pasteur Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof
US6756489B1 (en) * 1997-08-08 2004-06-29 Aventis Pharma Deutschland Gmbh Substituted tetrahydropyrane derivatives, method for producing same, their use as medicine or diagnostic agent, as well as medicine containing same
CN1191093C (zh) * 1998-10-30 2005-03-02 第一制药株式会社 Dds化合物及其测定方法
WO2000030444A1 (en) * 1998-11-25 2000-06-02 Vanderbilt University Cationic liposomes for gene transfer
WO2002010219A1 (en) * 2000-07-26 2002-02-07 Cho, Sung-Woo Oligolysine transducing domain, oligolysine-cargo molecule complex and uses thereof
CA2822457C (en) 2001-12-14 2016-03-08 The University Of Wyoming Methods and compositions for controlled resease of drugs
CN103804458B (zh) * 2014-02-25 2016-08-24 中国人民解放军第四军医大学 基于胆固醇的三种脂质材料的制备及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3226379A (en) * 1964-01-14 1965-12-28 Grace W R & Co Novel 1,3-bis(polyhydroxyalkyl)-2-imidazolidinones and 1,3-bis(polyhydroxyalkyl)-imidazolidine-2-thiones
US3859337A (en) * 1969-06-11 1975-01-07 Stauffer Chemical Co Ethylenediaminetetraacetic acid anhydride derivatives
US3953594A (en) * 1971-08-13 1976-04-27 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Process for preparing bleomycin group antibiotics
IT1050366B (it) * 1972-10-18 1981-03-10 Chinos Ind Farmacobilologica S Sali di amminoacidi con esteri polisolforici di glicopeptidi naturali e loro preparazione
US4195128A (en) * 1976-05-03 1980-03-25 Bayer Aktiengesellschaft Polymeric carrier bound ligands
SE431758B (sv) * 1977-03-04 1984-02-27 Pharmacia Fine Chemicals Ab Som tioleringsreagens eller berarmatris for enzymer anvendbart derivat av en sh-grupphaltig polymer
US4120953A (en) * 1977-04-04 1978-10-17 American Cyanamid Company Novel 2,2', 2"-[s-phenenyltris(sulfonylimino)tris]-[2-deoxy-α-D-glucopyranose], dodecakis (H-sulfate) compounds and their salts
US4241053A (en) * 1978-08-25 1980-12-23 Tanabe Seiyaku Co., Ltd. Novel nitrosourea compounds and process for preparing the same
US4223013A (en) * 1978-12-29 1980-09-16 Syva Company Amitriptyline conjugates to antigenic proteins and enzymes
US4267102A (en) * 1979-03-05 1981-05-12 Nippon Kayaku Kabushiki Kaisha Bleomycin group antibiotics
JPS5646897A (en) * 1979-09-26 1981-04-28 Seiichi Shibata Novel glycopeptide
US4259233A (en) * 1979-10-23 1981-03-31 Miles Laboratories, Inc. β-Galactosyl-umbelliferone-labeled protein and polypeptide conjugates
CA1203532A (en) * 1980-07-10 1986-04-22 Chembiomed Ltd. Synthesis of tumor antigenic determinant

Also Published As

Publication number Publication date
PT74747B (en) 1985-01-08
EP0063373B1 (en) 1986-03-12
PT74747A (en) 1982-05-01
IE52473B1 (en) 1987-11-11
JPS57181095A (en) 1982-11-08
GR76475B (es) 1984-08-10
IE820898L (en) 1982-10-20
EP0063373A1 (en) 1982-10-27
US4386026A (en) 1983-05-31
DK173282A (da) 1982-10-21
DE3269778D1 (en) 1986-04-17
ES8306162A1 (es) 1983-05-01
ATE18562T1 (de) 1986-03-15

Similar Documents

Publication Publication Date Title
ES511516A0 (es) Un procedimiento para la preparacion de glicopeptidos.
US5597578A (en) TGF-β protein compositions for inhibition of cell proliferation
Ashwell et al. Hepatic recognition and catabolism of serum glycoproteins
Masquelier et al. Low-density lipoprotein as a carrier of antitumoral drugs: in vivo fate of drug-human low-density lipoprotein complexes in mice
HU912442D0 (en) Process for the production of medical preparations with continuous active agent release
DE69812727D1 (de) Opioid-konjugate mit endogenen Trägerproteinen
KR20040043113A (ko) 당뇨병의 치료방법
SE8902638D0 (sv) Stabilized protein or peptide conjugates
CA2093806A1 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
DE3579068D1 (de) Arzneimittelenthaltende matrizen fuer einfuehrungen in zonen mit cellularen lesionen.
Johnson et al. Effect of sulfation on the gastrointestinal actions of caerulein
AU7479796A (en) Preparation of peptide containing biodegradable microspheres by melt process
ATE75945T1 (de) Pharmazeutische zubereitung zur behandlung des diabetes mellitus.
BR0016339A (pt) Composição de lcrf, conjugado de lcrf, composição de peptìdeo, complexo de lcrf conjugado a ligando múltiplo, complexo de polissorbato, complexo de lcrf conjugado, aquosamente solúvel estável, forma de dosagem de administração oral para o tratamento da obesidade, métodos de tratamento da obesidade em um paciente mamìfero humano ou não humano, de tratamento modo profilático ou intervencional da obesidade potencial ou desenvolvida em um paciente mamìfero humano ou não humano e de prolongamento da atividade de lcrf em um sistema in vivo ou in vitro, e, composto
KR910007518A (ko) 서방성 제제
NO973884D0 (no) Aminosyrepreparater og anvendelse derav for klinisk ernæring
EP0177342A3 (en) Oral formulation of therapeutic proteins
KR890000520A (ko) 폴리펩티드
Melton et al. Covalent linkage of carboxypeptidase G2 to soluble dextrans—II: in vivo distribution and fate of conjugates
EP0374532A3 (en) Improved phase separation-microencapsulated pharmaceutical compositions useful for alleviating dental disease
Mayou et al. Sudoriferous hamartoma
Code The recognition and assay of gastrone
Duncan et al. Biological evaluation of soluble synthetic polymers as drug carriers
SU651812A1 (ru) Способ предупреждени образовани спаек
Younger et al. Protective effects of ileal bypass versus administration of clofibrate on experimental hypercholesterolemia and atherosclerosis in monkeys

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401